BALBI, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 408
NA - Nord America 364
AS - Asia 164
AF - Africa 9
OC - Oceania 3
SA - Sud America 2
Totale 950
Nazione #
US - Stati Uniti d'America 362
IT - Italia 153
IE - Irlanda 104
SG - Singapore 86
SE - Svezia 65
CN - Cina 62
DE - Germania 24
FI - Finlandia 13
GB - Regno Unito 12
CI - Costa d'Avorio 8
IN - India 5
IR - Iran 5
LU - Lussemburgo 5
AT - Austria 4
CZ - Repubblica Ceca 4
AU - Australia 3
BE - Belgio 3
FR - Francia 3
NL - Olanda 3
TR - Turchia 3
UA - Ucraina 3
BG - Bulgaria 2
BR - Brasile 2
CA - Canada 2
HK - Hong Kong 2
LT - Lituania 2
MD - Moldavia 2
RU - Federazione Russa 2
CH - Svizzera 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PL - Polonia 1
Totale 950
Città #
Chandler 113
Dublin 104
Singapore 69
Ashburn 46
Boardman 32
Shanghai 30
Parma 25
New York 20
Verona 16
Bologna 15
Helsinki 13
Beijing 11
Milan 11
Munich 10
Princeton 10
Trento 9
Abidjan 8
Ann Arbor 8
London 7
San Giuliano Milanese 7
Bremen 6
Assago 4
Des Moines 4
Frankfurt am Main 4
Reggio Emilia 4
Turin 4
Vienna 4
West Jordan 4
Brescia 3
Brussels 3
Chicago 3
Edinburgh 3
Florence 3
Fremont 3
Kyiv 3
Melbourne 3
Wilmington 3
Amsterdam 2
Brno 2
Central 2
Chisinau 2
Dallas 2
Fairfield 2
Houston 2
Hyderabad 2
Kocaeli 2
Los Angeles 2
Marseille 2
Neviano degli Arduini 2
Piacenza 2
Pune 2
Rome 2
Santa Clara 2
Seattle 2
Sissa 2
Sofia 2
Taglio Di Po 2
Tehran 2
Toronto 2
Treviso 2
Vicenza 2
Zevio 2
Altedo 1
Amersfoort 1
Arezzo 1
Atlanta 1
Bagnacavallo 1
Bibbiano 1
Chauche 1
Chengdu 1
Corno di Rosazzo 1
Empoli 1
Fuyang 1
Gdansk 1
Genoa 1
Guangzhou 1
Hangzhou 1
Istanbul 1
Jiaxing 1
Lagos 1
Leawood 1
Luxembourg 1
Manila 1
Miami 1
Mönchengladbach 1
Nanning 1
New Delhi 1
Olomouc 1
Pescara 1
Podgorica 1
Prague 1
Redmond 1
Rio de Janeiro 1
Rizhao 1
Salvador 1
Salò 1
Sorbolo 1
Trieste 1
Vezzano sul Crostolo 1
Vilnius 1
Totale 713
Nome #
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 87
Frequency and characterization of ancillary chest CT findings in COVID-19 pneumonia 78
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 76
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 73
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 66
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 64
Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patients 56
Review on radiological evolution of COVID-19 pneumonia using computed tomography 55
Integrated Radiologic Algorithm for COVID-19 Pandemic 47
Imaging in non-cystic fibrosis bronchiectasis and current limitations 46
Interstitial lung abnormalities: new insights between theory and clinical practice 44
Impact of the COVID-19 pandemic on the selection of chest imaging modalities and reporting systems: a survey of Italian radiologists 43
Diameter versus volumetry: A narrative review on current recommendations to measure and monitor screening detected lung nodules 43
Structured reporting of lung cancer staging: A consensus proposal 39
The radiological appearances of lung cancer treated with immunotherapy: a review 36
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 25
Automated Coronary Artery Calcium and Quantitative Emphysema in Lung Cancer Screening: Association With Mortality, Lung Cancer Incidence, and Airflow Obstruction 25
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 21
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 20
P57.08 High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC 15
Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial 15
Totale 974
Categoria #
all - tutte 5.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 13 3 2 2 1
2021/202261 2 2 10 0 4 0 12 3 1 0 8 19
2022/2023436 31 48 22 33 57 40 9 37 127 3 18 11
2023/2024261 20 16 10 11 33 51 43 10 14 10 14 29
2024/2025195 23 37 60 54 21 0 0 0 0 0 0 0
Totale 974